share_log

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga ·  Apr 17 08:08

Gainers

  • INVO Bioscience (NASDAQ:INVO) shares increased by 93.4% to $1.47 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.8 million. As per the press release, Q4 earnings came out yesterday.
  • Clene (NASDAQ:CLNN) shares moved upwards by 40.8% to $0.44. The market value of their outstanding shares is at $56.0 million.
  • Galera Therapeutics (NASDAQ:GRTX) shares moved upwards by 31.76% to $0.22. The market value of their outstanding shares is at $12.1 million.
  • Vanda Pharma (NASDAQ:VNDA) stock moved upwards by 26.91% to $5.14. The company's market cap stands at $295.7 million.
  • Chromocell Therapeutics (AMEX:CHRO) shares moved upwards by 23.62% to $2.25. The market value of their outstanding shares is at $12.9 million.
  • BIMI Intl Medical (NASDAQ:BIMI) shares moved upwards by 16.98% to $1.86. The company's market cap stands at $26.0 million.

Losers

  • Sage Therapeutics (NASDAQ:SAGE) stock decreased by 19.4% to $12.6 during Wednesday's pre-market session. The market value of their outstanding shares is at $757.3 million.
  • Ontrak (NASDAQ:OTRK) stock declined by 17.81% to $0.38. The company's market cap stands at $16.0 million. The company's, Q4 earnings came out yesterday.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares declined by 17.29% to $1.34.
  • Dynatronics (NASDAQ:DYNT) shares decreased by 11.91% to $0.48. The company's market cap stands at $2.3 million.
  • Etao International Co (NASDAQ:ETAO) shares declined by 11.89% to $3.3. The market value of their outstanding shares is at $16.9 million.
  • Precision BioSciences (NASDAQ:DTIL) shares declined by 10.96% to $11.46. The market value of their outstanding shares is at $79.2 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment